The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure

Andrew L Clark1, Kevin Goode, John G F Cleland

  • 1Department of Academic Cardiology, Castle Hill Hospital, Castle Road, Cottingham, Hull, UK. HU16 5JQ, UK. a.l.clark@hull.ac.uk

Insights

Left bundle branch block (LBBB) affects one-third of heart failure patients. New LBBB is an independent adverse prognostic indicator, highlighting the need for regular ECG monitoring in chronic heart failure care.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Left bundle branch block (LBBB) is prevalent in approximately one-third of patients diagnosed with chronic heart failure.
  • The presence of LBBB on a 12-lead electrocardiogram (ECG) in heart failure patients warrants further investigation due to its potential prognostic implications.

Purpose of the Study:

  • To determine the incidence of new-onset LBBB in ambulatory patients with chronic stable heart failure.
  • To evaluate the prognostic significance of baseline LBBB and incident LBBB in this patient population.

Main Methods:

  • A cohort of 1418 consecutive patients with chronic heart failure were analyzed, with baseline 12-lead ECGs recorded.
  • Follow-up ECGs were obtained for a subset of patients (52%) at one year to assess changes in QRS duration and the incidence of LBBB.
  • Statistical analysis was performed to identify predictors of incident LBBB and its association with patient outcomes.

Main Results:

  • The incidence of new LBBB in the first year was 10.9%.
  • Baseline QRS duration and amiodarone use were the sole predictors of incident LBBB.
  • New LBBB was identified as an independent adverse prognostic factor, associated with a significantly worse outcome (HR 2.09).

Conclusions:

  • The crude incidence of LBBB is 10.9% within the first year in an unselected group of outpatients with chronic stable heart failure.
  • Regular 12-lead ECG monitoring should be an integral part of ongoing care for patients with chronic heart failure to detect new LBBB.
  • The development of new LBBB signifies a worse prognosis and necessitates close clinical attention.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...